Financials
- Market Capitalization 517.63 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2885 | OVID Ovid Therapeutics Inc. - Common Stock | 2.69 USD | -3.93% | -2.54% | +21.17% | +115.20% | 525.35 M USD | ||
| 2892 | ENTX Entera Bio Ltd. - Ordinary Shares | 3.00 USD | -0.99% | -12.02% | +3.09% | +54.64% | 519.43 M USD | ||
| 2940 | EVMN Evommune, Inc. Common Stock | 13.22 USD | -1.56% | -3.43% | +18.67% | -23.67% | 479.78 M USD | ||
| 2948 | PRTA Prothena Corporation plc - Ordinary Shares | 9.23 USD | -1.07% | -1.07% | +12.97% | +12.97% | 473.84 M USD |